Alexander Nichols

enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.

QD Vision, Inc. develops nanotechnology-based optical products for display and solid state lighting applications. Its materials and components are used to illuminate applications, including flat panel displays, solid state lighting systems, and defense and security projects. The company was founded by Jonathan S. Steckel, Joe J. Caruso, Seth Coe-Sullivan, Gregory V. Moeller and Vladimir Bulovic in 2004 and is headquartered in Lexington, MA.

Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.